Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Foreign Bribery Investigations Ramping Up, Along With 'Carrot' For Cooperation

Executive Summary

Pilot program from DOJ reduces fines for companies that voluntarily disclose misconduct; focus of investigations is broadening from sales to suppliers.

Advertisement

Related Content

Sanofi FCPA Settlement Follows Drought In Pharma Foreign Bribery Cases
Herbalife Under SEC Scrutiny On Regulatory Compliance In China
Teva's Foreign Bribery Settlement Shatters Record For Rx Sector
Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors
Pfizer Settles Foreign Bribery Charges, Wins Deferred Prosecution For Helping Government
J&J Takes The Lead In Settling SEC/DoJ Foreign Corrupt Practices Act Probe

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS057582

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel